HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Sector Settlements Frame FTC Guidance On Direct Sellers' Compensation Claims

This article was originally published in The Rose Sheet

Executive Summary

Guidance notes settlements Herbalife and Vemma Nutrition made in 2016 as examples of its enforcement policies. FTC prohibition against misleading claims extends to requiring direct sellers to base claims of distributors' compensation on sales to consumers, not on measures such recruiting more distributors.

You may also be interested in...



Responsibility For Distributors’ Claims At Root Of Supplement Direct Seller’s Advertising Review

After the DSSRC recommended that Root Wellness remove health claims from its advertising in 2021, the direct seller has not made efforts to remove the claims that its ambassadors have made on social media.

Supplements Mixed With Direct Selling A Recipe Ripe For Cooking US FTC Regulation Violations

Doesn’t take long to find health and wellness product marketers on list of direct sellers or find firms offering those products in the FTC's history of enforcement actions in the sector. 

FTC Warns Health And Wellness Direct Sellers Preying On Pandemic-Stressed Consumers

FTC warned 10 US direct sellers about false claims for health and wellness products that prey on consumer fears over COVID-19. The agency says it will continue to monitor the market for unfounded health claims as well as direct sellers' statements about distributors' potential earnings.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121397

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel